SITRAN LUNCHTIME SEMINAR – MONDAY 18 DECEMBER 2017 – Professor Anne Rosser, Professor of Clinical Neuroscience, Cardiff University

Title: “Transplants in Huntingon’s Disease: progress and challenges” Speaker: Professor Anne Rosser, Professor of Clinical Neuroscience, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine,  Cardiff  University Venue: Rooms B02/B03, SITraN, 385a Glossop Road, Sheffield S10 2HQ Background Professor Anne Rosser is Chair of UK Huntington’s disease network, Lead for the English speaking sector of the European HD network,…

Continue reading →

SITraN Lunchtime Seminar: Monday 13 November 2017: 13:00 – 14:00: Dr John Davies, Chief Scientific Officer of the Oxford ARUK Drug Discovery Institute

Title: “New approaches to the crisis in finding therapies for neurodegenerative diseases underlying dementia. (What the ARUK Oxford Drug Discovery Institute can do for you)” Speaker: Dr John Davies,  Chief Scientific Officer of the Oxford ARUK Drug Discovery Institute Venue: Rooms B02/B03, SITraN, 385a Glossop Road, Sheffield S10 2HQ Background The Alzheimer’s Research UK Oxford Drug Discovery…

Continue reading →

SITraN Lunchtime Seminar: Wednesday 1 November 2017: 13:00 – 14:00: Jennifer Hirst and Alexandra Davies from Cambridge Institute for Medical Research

Title:   “Mechanistic insights into the role of AP-4 and AP-5 adaptor protein complexes                  in neurodegeneration” Speakers: Jennifer Hirst and Alexandra Davies, Cambridge Institute for Medical                                     Research, University of Cambridge Venue:…

Continue reading →

SITraN Seminar: Monday 16 October 2017: 13:00 – 14:00: Richard Wade-Martins, Professor of Molecular Neuroscience, University of Oxford

Title:  “Translating Parkinson’s: from molecular mechanisms to target discovery” Speaker:  Professor  Richard Wade-Martins, Professor of Molecular Neuroscience,  Department of Physiology,  Anatomy and Genetics, University of Oxford Venue: Rooms B02/B03, SITraN, 385a Glossop Road, Sheffield, S10 2HQ Background Richard graduated from Cambridge in Natural Sciences taking Part II Genetics in 1995. He then moved to the Wellcome Trust…

Continue reading →

SITraN Seminar: Monday 18 September 2017: 13:00 – 14:00: Professor Jackie Hunter, Chief Executive Officer of Benevolent Bio, London

Title:  “The importance of AI on Drug Discovery” Speaker:  Professor Jackie Hunter, Chief Executive, Benevolent Bio, CBE PhD HonDSc FMedSci FBPharmacolS FRSB Venue: Rooms B02/B03, SITraN, 385a Glossop Road, Sheffield, S10 2HQ Background Jackie Hunter is the Chief Executive Officer of Benevolent Bio. Benevolent Bio unites traditional pharmaceutical development methodology with Artificial Intelligence to augment…

Continue reading →